Why all the fuss?
Apoquel® is an innovative, rapid onset oral therapy for pruritus associated with allergic dermatitis and clinical manifestations of atopic dermatitis in dogs.
The launch of this product in the USA, UK and Germany was so successful in 2014, that demand rapidly outstripped supply thus delaying the launch of Apoquel® in other countries. We are delighted to announce that Apoquel® is now available for customers in Ireland from our usual wholesalers.
What is Apoquel?
Apoquel® contains oclacitinib maleate which is Janus Kinase (JAK) inhibitor. Oclacitinib inhibits the function of a variety of cytokines dependent on JAK enzyme activity. Most of these cytokines bind to specific cell receptors and signal through the JAK/STAT pathway, leading to a cascade of intracellular events that induce both pruritus and inflammation.